Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Clinical trial NCT01718743 · COMPLETED

Trial details

NCT number: NCT01718743
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic Cell Transplantation Recipient Plasma Cell Myeloma

Start date: 2012-12-03
Primary completion: 2023-04-12
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.